Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Boehringer Ingelheim
McKesson
McKinsey
Baxter

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Fasudil

« Back to Dashboard

US Patents for Fasudil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fasudil ➤ Try a Free Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA) ➤ Try a Free Trial
Fasudil ➤ Try a Free Trial Veterinary compositions against endoparasites containing cypermethrin and albendazole Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. (Budapest, HU) ➤ Try a Free Trial
Fasudil ➤ Try a Free Trial Anthelmintic active compound combinations Bayer Aktiengesellschaft (Leverkusen, DE) ➤ Try a Free Trial
Fasudil ➤ Try a Free Trial Substituted 1,3,4-oxa (thia) diazolinones process for their preparation and their use of combating endoparasites Bayer Aktiengesellschaft (Leverkusen, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Fasudil

Drugname Country Document Number Estimated Expiration Related US Patent
Fasudil European Patent Office 2981556 2033-04-02 ➤ Try a Free Trial
Fasudil World Intellectual Property Organization (WIPO) 2014165513 2033-04-02 ➤ Try a Free Trial
Fasudil Argentina 241631 2008-08-09 ➤ Try a Free Trial
Fasudil Austria 96314 2008-08-09 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Daiichi Sankyo
Federal Trade Commission
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.